01P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Medpace Holdings Inc

Watchlist Manager

Watchlist

Price: 355 EUR -17.86% Market Closed

Market Cap: €6.3B

M	Medpace Holdings Inc SWB:01P	US
B	Biogen Inc DUS:IDP	US
	Xpel Inc F:XPX	US
B	BCE Inc F:BCE1	CA
	Quanta Computer Inc TWSE:2382	TW
	China Life Insurance Co Ltd SSE:601628	CN
T	Takeda Pharmaceutical Co Ltd OTC:TKPHF	JP
V	Virtus Investment Partners Inc F:VIP	US
	Rugvista Group AB (publ) F:81N	SE
B	Banca Popolare Di Sondrio SpA DUS:593	IT
	Peraso Inc F:N6Z0	US

Profitability Summary

Medpace Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

29%

Sustainable 3Y Average Gross Margin

30%

Declining Gross Margin

29% > 29%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

20%

Operating Margin is Increasing

19% > 21%

Healthy Net Margin

17%

Sustainable 3Y Average Net Margin

17%

Net Margin is Increasing

16% > 17%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

25%

Free Cash Flow Margin is Increasing

22% > 27%

Exceptional ROE

77%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

26%

ROIC is Increasing

21% > 32%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.